Acadian Asset Management buys $153,784,203 stake in Bruker Corporation (BRKR)

Bruker Corporation (BRKR) : Acadian Asset Management scooped up 2,740,421 additional shares in Bruker Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Jul 19, 2016. The investment management firm now holds a total of 6,243,776 shares of Bruker Corporation which is valued at $153,784,203.Bruker Corporation makes up approximately 0.76% of Acadian Asset Management’s portfolio.

Other Hedge Funds, Including , First Quadrant L Pca reduced its stake in BRKR by selling 394,477 shares or 42.85% in the most recent quarter. The Hedge Fund company now holds 526,051 shares of BRKR which is valued at $12,956,636. Bruker Corporation makes up approx 0.28% of First Quadrant L Pca’s portfolio.Nn Investment Partners Holdings N.v. reduced its stake in BRKR by selling 7,892 shares or 21.82% in the most recent quarter. The Hedge Fund company now holds 28,278 shares of BRKR which is valued at $707,516. Bruker Corporation makes up approx 0.01% of Nn Investment Partners Holdings N.v.’s portfolio. Cutler Group Lp sold out all of its stake in BRKR during the most recent quarter. The investment firm sold 283 shares of BRKR which is valued $7,081.Alpha Windward reduced its stake in BRKR by selling 546 shares or 37.73% in the most recent quarter. The Hedge Fund company now holds 901 shares of BRKR which is valued at $21,336. Bruker Corporation makes up approx 0.02% of Alpha Windward’s portfolio.

Bruker Corporation opened for trading at $24.42 and hit $25.01 on the upside on Wednesday, eventually ending the session at $24.63, with a gain of 0.94% or 0.23 points. The heightened volatility saw the trading volume jump to 6,24,250 shares. Company has a market cap of $3,977 M.

On the company’s financial health, Bruker Corporation reported $0.21 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on May 4, 2016. Analyst had a consensus of $0.15. The company had revenue of $375.40 million for the quarter, compared to analysts expectations of $360.07 million. The company’s revenue was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.14 EPS.

Many Wall Street Analysts have commented on Bruker Corporation. Company shares were Reiterated by Mizuho on May 5, 2016 to “Neutral”, Firm has raised the Price Target to $ 28 from a previous price target of $22 .Company shares were Reiterated by Barclays on May 5, 2016 to “Overweight”, Firm has raised the Price Target to $ 32 from a previous price target of $30 .

Bruker Corporation is a designer and manufacturer of life science and materials research systems and associated products that address the needs of a range of customers in life science research pharmaceuticals applied markets nanotechnology cell biology clinical research microbiology and in-vitro diagnostics. The Company operates through two segments: Bruker Scientific Instruments (BSI) and Bruker Energy & Supercon Technologies (BEST). BSI is organized into three operating segments: the Bruker BioSpin Group the Bruker CALID Group and the Bruker Nano Group. BEST designs manufactures and distributes superconducting materials. The company maintains technical and manufacturing centers in Europe and North America and it has sales offices located throughout the world.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *